MedWatch

Ambu appoints Britt Meelby Jensen new CEO

Juan Jose Gonzalez steps down as chief executive of Ambu on May 20, as Britt Meelby Jensen assumes charge. (Updated)

Britt Meelby Jensen | Photo: Atos Medical

Effective tomorrow, May 20, Juan Jose Gonzalez will no longer be the chief executive of Danish medtech firm Ambu, the firm has announced in a press release.

His place at the helm will be taken over by Britt Meelby Jensen, who has been a board member of Ambu since 2019, a position she leaves as part of the executive reshuffle. She has also previously served in a similar role as CEO of Swedish Atos Medical, until the company was sold off to Coloplast in early 2022.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs